Reader Ad Slot
Reader Ad Slot placeholder
If you would like to support SpookStack without paying out of pocket, please consider allowing advertising cookies. It helps cover hosting costs and keeps the archive free to browse. You can change this choice at any time.
Amerithrax — Part 27
Page 90
90 / 108
2
.
a
“
DAY 3: ee
. b7c
Alternate: Combine categories #7 and #8: Immu is and Treatment
Chairmen:
#7: Vaccines and immune responses
Co-Chairmen: land B. Ivins
AVA and rPA vaccine potency and safety: comparisons in animals
(Ivins orf]
Efficacy of AVA against vaccine-refractory strains
r Ivins)
DNA vaccin ‘
(eg ER)
(or - etal.) ‘
PAproqucing recombinant B.anthracis vaccines
LF-fusion pretense
Other experimental vaccines:
(Live attenuated recombinant vaccine
Correlates of immune protection (possible subjects . . )
In vitro correlate/animal models
USAMRHD
pena(ce,___ |
Human immune responses to anthrax vaccine {|
The SCID mouse model-
#8: Prevention and Treatment [Or Human Vaccines and Treaimenis]
Chairmen:
Anthrax vaccination: Safety and immunogenicity of alternate schedules and routes:
|
seven of military personnel immunized with AVA:
Human Clinical studies with PAVAX
Human antitoxin antibodies
("scFV": [stl Alamos)
Toxin competitive inhibitors .
cpas2"[ tg Los Alamos)
Reveal the original PDF page, then click a word to highlight the OCR text.
Community corrections
No user corrections yet.
Comments
No comments on this document yet.
Bottom Reader Ad Slot
Bottom Reader Ad Slot placeholder
If you would like to support SpookStack without paying out of pocket, please consider allowing advertising cookies. It helps cover hosting costs and keeps the archive free to browse. You can change this choice at any time.
Continue Exploring
Reader
Topic
Agency Collection
Explore This Archive Cluster
Broad Topic Hub
Topic Hub
investigation
Related subtopics
Subtopic
Subtopic
Subtopic
Subtopic
Subtopic
Subtopic